Newsfiscal.ai
UBS Adjusts Assembly Biosciences Price Target to $48 From $52
· Published
Article summary
UBS has revised its price target for Assembly Biosciences, Inc. from $52 to $48 while maintaining a Buy rating.
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…


Comments —
Loading comments…